Patents

US 12473344 B2: Chimeric antigen receptor polypeptides and methods of using same

Granted
2025-11-18
Filed
2019-07-03 application 17254618
Type
Utility · 10 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided are polypeptides that include, from N-terminus to C-terminus, a chimeric antigen receptor (CAR), a protease, and a degron, where the polypeptide further includes a cleavage site for the protease disposed between the CAR and the degron. Also provided are cells that include such polypeptides (e.g., where the cells express the CAR on their surface) and pharmaceutical compositions including such cells. Nucleic acids that encode the polypeptides, cells including such nucleic acids, and pharmaceutical compositions including such cells, are also provided. Also provided are methods for controlling the expression of a CAR on the surface of a cell, and methods of using the cells of the present disclosure, including methods of using such cells to administer a regulatable CAR cell-based therapy (e.g., a regulatable CAR T cell therapy) to an individual.

Source: PVGPATDIS, file of 2026-04-10 (ipg251118.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
The Board of Trustees of the Leland Stanford Junior University 3,100 patentsUS company or organizationStanford, CAStanford University College or university EXACT high confidence: through the nonprofit with the college's EIN (identical full name and state)
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Crystal MackallStanford, CA21PVGPATDIS, file of 2026-04-10
Michael Z. LinStanford, CA8PVGPATDIS, file of 2026-04-10
Robbie MajznerPalo Alto, CA4PVGPATDIS, file of 2026-04-10
Hokyung ChungSan Diego, CA3PVGPATDIS, file of 2026-04-10
Louai LabaniehStanford, CA2PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K14/7051PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K31/426PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N9/506PVGPATDIS, file of 2026-04-10
C12YEnzymesC12Y304/21098PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-03-24Assignment
Assignment of assignor's interest
LIN, MICHAEL signed 2020-12-21
CHUNG, HOKYUNG signed 2021-03-17
LABANIEH, LOUAI signed 2021-03-17
MACKALL, CRYSTAL signed 2021-03-18
MAJZNER, ROBBIE signed 2021-03-18
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY STANFORD, CA55700/120ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.